Former UFC light heavyweight champion and BioXcellerator client Chuck Liddell
Getty Images
Presented by BioXcellerator
I'm very lucky that I'll be able to tell my kids that if you ever face a serious injury or problem in the future I can provide you with a solution that might not involve normal medicine, that could heal or help you get back to where you need to be, explains Michael Alexander, Chief Marketing Officer for BioXcellerator.
And at the same time it is a way to challenge the status quo, push the boundaries of medicine and instill in society that the fight for a cure to the incurable is very much alive. Now that's cool.
We are discussing the benefits of stem cells, or more specifically stem cell research and therapy. A promising edge on the frontier of medicine, stem cell therapy (SCT) has shown remarkable results in how it can extend longevity, boost immunity and enhance overall quality of life while reducing the impact of aging.
Specifically mesenchymal stem cells (MSCs) an undifferentiated cell capable of giving rise to indefinitely more cells of the same type. Meaning these unformed cells can evolve into any cell in your body, boasting remarkable regenerative healing properties.
In fact, all tissue repair in the body is initiated by stem cells. Proponents of SCT promise applications include repairing spine and disc conditions, sports and orthopedic injuries, debilitating autoimmune disorders (e.g. Lupus, rheumatoid arthritis, multiple sclerosis, Type 1 diabetes, Parkinson's, etc.), neurologic conditions, traumatic brain injuries, Alzheimer's and CTE, sexual wellness and even hair treatments and skin rejuvenation to diminish scars and wrinkles.
BioXcellerators CEO Eric Stoffers has even stated: "Our moonshot goal is to make age 100 the new 60, so more people can both live longer and enjoy better health in later years."
While these claims may seem hyperbolic, the effectiveness of SCT is well documented, with evidence of its efficacy supported by volumes of independent research and trials. The deep-pocketed attacks on SCT come largely from the pharmaceutical industry who would potentially lose billions if the burgeoning science replaces their treat but never heal philosophy. Please do your own research and due diligence if you consider any form of SCT, but its hard not to take interest in any industry to which Big Pharma aims its crosshairs to.
WWE wrestler Bobby Lashleyreceiving treatment at BioXcellerator
BioXcellerator
A physiologist who spent multiple years working in the healthcare industry before pivoting his focus to BioXcellerator, Alexanders role as CMO is to translate the complex medicine of SCT into simple-to-understand information for patients.
How you make 100 the new 60 is you give people beyond 60 the opportunity to continue to live their normal life, which can be stripped from you as you get older because of issues related to bone and tissue deterioration, Alexander explains. Those are big, but also being able to keep the body healthy at the molecular level through IV stem cells can improve the body's ability to heal internally, keep the organs healthy. Those aspects are critical to helping people live into their twilight years.
With 22 years of clinically based research BioXcellerator has evolved into one of the worlds premier stem cell research and treatment centers.
Former UFC featherweight champion and BioXcellerator client Cris Cyborg
BioXcellerator
Their gleaming new 10,000 square-foot facility in the modern heart of Medellin, Colombia has welcomed a litany of superstar athletes: elite performers like Super Bowl-winning former Chicago Bears QB Jim McMahon and Dallas Cowboys receiver Billy Davis, WWE wrestler Bobby Lashley, former UFC light heavyweight champion Chuck Liddell, current UFC welterweight champion KamaruUsman, UFC fighter Jorge Masvidal, and former UFC featherweight champion Cris Cyborg.
These are men and women incurring massive damage to their bodies, and the fact they trust in BioXcellerator and look to the Colombian clinic to heal their war-torn bodies say more than any smirking reality star ever could. In total BioXcellerator boasts a grocery list of UFC fighters, professional wrestlers, NFL and Olympic athleteswho theyve treated. (Aside from top athletes, movers and shakers including restaurant mogul Michael Chernow and musician Rohan Marley have also received BioXcellerator treatments.)
Testosterone replacement, hormone replacement, bio-regulatory, bio-hacking, etc. are all terms used to death in the United States and across the world because we've learned that people can stay healthier longer if they can maintain what they used to have at a younger age, relates BioX Chief Medical Officer Dr. Karolynn Halpert.
It's the same exact type of thing with cells: providing your body with a new kind of cell that allows it to heal from within, even if you're as healthy as can you be, you're going to get positive outcomes and preventative measures for the future."
BioXcellerator has taken the therapy a step further by pioneering a proprietary process to assure their patients receive the most potent stem cells possible: Golden Cells. These cells are created with MSCs sourced from Wharton jelly in donated umbilical cords. The process screens for specific proteins and genes that identify cells that have the highest levels of anti-inflammatory and immune modulation properties in order to provide superior regeneration and healing potential.
Cells that come from Wharton jelly are new, those cells are pre-dispositioned to activate as if they are entering the body at a brand-new stage where everything is full max all the time. Whereas MSCs taken from your own body, a common practice inside the United States, have been used by that body in different capacities for a long period of time, explains Alexander.
Restaurateur Michael Chernowreceiving treatment at BioXcellerator
BioXcellerator
Because of that, they may not have the same level of impact on the human biology as brand-new cells do. The only purpose of these zero level cells is to rebuild, repair and maintain at those younger age levels. Alexander goes on to make an analogy to a Xerox machine making copies of an original versus off of multiple copies, and how the quality fades the more you separate from the original.
With MSCs some are more potent than others, and we take those and we put them through a culture expansion process that allows those cells to replicate into larger amounts that we can provide to our patients, adds Dr. Halpert. This assures them they're going to get a high-quality and high-dosage that's going to help them with whichever issues they're treating.
Since the culture expansion of cells cannot be done in the United States, these forms of SCT are only available at offshore clinics like BioXcellerator. No matter where you choose to receive your therapy, however, Alexander cautions you to vet your clinic and doctors judiciously.
There's a lot of snake oil salesmen everywhere, including the United States. I'm not afraid to tell people that you have to be very careful you should be cautious with us, you should do your research, stresses the CMO.
Musician and BioXcellerator client Rohan Marley
BioXcellerator
These are experimental procedures. If you're buying it from a seminar and there are 5,000 other people there and you spend $2,500 to get a biologic and they're going to fill you up at their chiropractic clinic around the corner, you probably need to take a step back and do some more research. Because that might not be safe.
There's obviously going to be people who take advantage of SCT and overpromise and under-deliver, he explains, yet Alexander remains highly bullish on the cutting-edge field, dubbing it future medicine. When you don't have to go under the knife, or when you can have no back pain, it puts you back on a trajectory to make your life healthy. So I believe it is absolutely the new frontier, Alexander vows.
There's a lot to be done, still. There's a lot of things that you have to shoot down that aren't real, but the medicine in its purest form is available, viable, and successful in a lot of aspects. Its definitely something that's going to expand and continue to grow over the next 20 years as society asks for other alternatives that aren't driven by pharmaceutical or other regulatory standards.
In the coming weeks, we'll be sharing testimonials from real-life BioXcellerator patients from superstar athletes to average civilians dealing with extraordinary challenges. Stay tuned.
Visit link:
- The therapeutic potential of stem cells - PubMed Central (PMC) - November 12th, 2024
- Stem Cell Therapy Market Is Projected To Achieve A Market Value Of USD 3.40 Bn. By 2030, Reflecting A Robus... - WhaTech - October 18th, 2024
- Doctor who provided ineffective stem cell therapies disciplined 6 years after investigation began - CBS Chicago - October 15th, 2024
- Study reveals the benefits and downside of fasting - Big Think - September 28th, 2024
- Tiny vesicles from umbilical cord blood may have therapeutic benefit - Parkinson's News Today - September 28th, 2024
- The Stem Cell Solution Review: Is This Program the Future of Anti-Aging and Recovery? - Enumclaw Courier-Herald - September 28th, 2024
- Cell and Gene Therapy Research To Benefit From New Stem Cell Collection Center - Technology Networks - September 25th, 2024
- Stem Cell Restore: A Full Review of Its Role in Promoting Regeneration and Vitality - Islands' Sounder - September 18th, 2024
- Is fasting good for you? A new study reveals some hidden risks and benefits of the practice - Business Insider India - August 31st, 2024
- Study reveals the benefits and downside of fasting - MIT News - August 27th, 2024
- Scilex Holding Company Announces the U.S. Patent and Trademark Office Will Be Issuing New ELYXYB® Patent Related to the Treatment of Acute Pain - August 22nd, 2024
- Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients - August 22nd, 2024
- Orion Corporation: Managers’ transactions – Niclas Lindstedt - August 22nd, 2024
- PharmaTher’s Sairiyo Therapeutics Announces Independent Screening Identifying Cepharanthine’s Potential to Bind to Monkeypox (Mpox) Proteins - August 22nd, 2024
- BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA PHARMACEUTICALS. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY... - August 22nd, 2024
- Eyenovia Announces Pricing of $5.14 Million Public Offering - August 22nd, 2024
- Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management... - August 22nd, 2024
- Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment - August 22nd, 2024
- SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX® - August 22nd, 2024
- MDxHealth Reports Q2 and Half Year 2024 Results - August 22nd, 2024
- Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country - August 22nd, 2024
- Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of... - August 22nd, 2024
- Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility - August 22nd, 2024
- Certara to Participate in Upcoming Investor Conferences - August 22nd, 2024
- Orion Corporation: Managers’ transactions – Satu Ahomäki - August 22nd, 2024
- Bavarian Nordic Announces First Half 2024 Results - August 22nd, 2024
- BioCryst to Present at Upcoming Investor Conferences - August 22nd, 2024
- Zymeworks Announces Participation in Upcoming Investor Conferences - August 22nd, 2024
- MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update - August 14th, 2024
- Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan - August 14th, 2024
- Shock Top and Gator Athletics Partner to Introduce First-Ever Craft Beer Sponsorship of the Florida Athletic Department - August 14th, 2024
- IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update - August 14th, 2024
- Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates - August 14th, 2024
- Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders - August 14th, 2024
- Evaxion Announces Business Update and Second Quarter 2024 Financial Results - August 14th, 2024
- Galera Announces Board Approval of Complete Liquidation and Dissolution - August 14th, 2024
- Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update - August 14th, 2024
- Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - August 14th, 2024
- Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research - August 14th, 2024
- CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update - August 14th, 2024
- Panavance Therapeutics Announces Foundational Publication of Misetionamide (GP-2250) in Ovarian Cancer in the Journal, Cancer Medicine - August 14th, 2024
- Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors - August 14th, 2024
- Veralox Therapeutics Announces EMA Orphan Drug Designation for VLX-1005 - August 14th, 2024
- Verrica Pharmaceuticals Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315, an Investigational Oncolytic... - August 14th, 2024
- Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results - August 14th, 2024
- Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons - August 14th, 2024
- Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis - August 14th, 2024
- Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates... - August 14th, 2024
- What Is Stem Cell Therapy? How Does It Work? - ThePrint - August 6th, 2024
- New Study Shows Short-Term Benefits of Stem Cell Therapy for MS Patients, But Long-Term Efficacy Remains Unclear - Managed Healthcare Executive - July 26th, 2024
- Cord Blood Awareness Month: Advantages of cord blood banking, things to keep in mind - Moneycontrol - July 10th, 2024
- Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous System - Frontiers - June 28th, 2024
- Harnessing benefits of stem cells for heart regeneration | ASU News - ASU News Now - June 21st, 2024
- 'Didn't know this would be possible': Autistic teen's mom on stem cell therapy benefits - WZTV - May 6th, 2024
- John Cleese says he's been spending 17,000 annually on stem cell therapy to 'buy a few extra years' - Yahoo News UK - April 24th, 2024
- Promethera Bets Liver-Derived Stem Cells Will Offer Benefits In NASH - Scrip - April 24th, 2024
- Stem Cell Therapies: Is This The Future Of Wellness? - Grazia USA - April 20th, 2024
- Signal of Benefit for Stem Cell Therapy in Progressive MS - Medscape - March 7th, 2024
- The Controversies Surrounding Stem Cell Therapy for Autism - The Portugal News - February 24th, 2024
- Benefits of Stem Cell Therapy - News Channel 5 Nashville - February 7th, 2024
- What is Stem Cell Therapy & How It Helps Others - Publicist Paper - January 31st, 2024
- A guide to stem cell therapy in Thailand - Thaiger - January 4th, 2024
- Half of pediatric patients with aHUS benefit from Soliris after... - AHUS News - December 21st, 2023
- Real world analysis on the determinants of survival in primary ... - Nature.com - December 5th, 2023
- The Best Beauty Gifts According To People Who Really Know Skin Care - HuffPost - December 5th, 2023
- The Eyepopping Factory Construction Boom in the US - WOLF STREET - December 3rd, 2023
- Benefit of Neoadjuvant Therapy Illustrated During ESMO Congress ... - Targeted Oncology - December 1st, 2023
- Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy ... - Curetoday.com - December 1st, 2023
- Review What Real Cavityn Customers Say About Benefits and Side ... - Seattle Weekly - December 1st, 2023
- 'There is a Scientific Fraud Epidemic' - Slashdot - Slashdot - December 1st, 2023
- 15 Best Hydrating Serums to Soothe Any Skin Type 2023 - Town & Country - December 1st, 2023
- Innovations in Cosmetic Dermatology: A Glimpse into the Future - APN News - December 1st, 2023
- FDA Probes New Cases of Cancer That May Stem From Cancer Cell ... - MedCity News - November 29th, 2023
- Use of plant stem cells in topical formulations on the rise - CosmeticsDesign.com USA - November 29th, 2023
- Stem cell-based treatment controls blood sugar in people with Type ... - EurekAlert - November 29th, 2023
- Biologics Market is projected to grow at a CAGR of 8.5% by 2034: Visiongain - Yahoo Finance - November 29th, 2023
- Scientists devise new technique that can pinpoint the causes and ... - EurekAlert - November 29th, 2023
- Global Advanced Therapy Medicinal Products Market is on the brink ... - PharmiWeb.com - November 29th, 2023
- Introducing Orgavalue - The 2023 EIT InnoStars Awards winner - EU-Startups - November 29th, 2023
- Episode 160: Euan Ashley discusses precision medicine and the ... - IHMC - November 29th, 2023
Recent Comments